Abstract
This paper distinguishes between inbound, outbound and coupled open innovation processes along upstream and downstream value chain activities and explores the impact of these open innovation processes on the innovation performance of new entrant and established firms in the UK bio-pharmaceuticals sector between 1991 and 2001. Our findings suggest that there may not always be a statistically significant relationship between open innovation processes and firm innovation performance and that the relationship can be ambiguous. The study supports that the distinction of inbound, outbound and coupled open innovation, offers a meaningful delineation facilitating our understanding of the role of openness in innovation performance of new entrant and established firms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
